These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21197568)

  • 21. Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.
    Zheng SL; Zheng W; Chang BL; Shu XO; Cai Q; Yu H; Dai Q; Xu J; Gao YT
    Cancer Res; 2003 Nov; 63(22):7624-9. PubMed ID: 14633679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
    Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast.
    Park SS; Kim JE; Kim YA; Kim YC; Kim SW
    Histopathology; 2005 Dec; 47(6):625-30. PubMed ID: 16324201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA; Dillon D; Carter D; Parisot N; Haffty BG
    Cancer; 2003 Mar; 97(6):1393-403. PubMed ID: 12627502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk.
    Yang Z; Shen J; Cao Z; Wang B
    Breast Cancer Res Treat; 2013 May; 139(1):267-75. PubMed ID: 23609471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
    Heikkinen T; Kärkkäinen H; Aaltonen K; Milne RL; Heikkilä P; Aittomäki K; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2009 May; 15(9):3214-22. PubMed ID: 19383810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between single-nucleotide polymorphisms and epidural ropivacaine consumption in patients undergoing breast cancer surgery.
    Liu J; Jiang Y; Pang D; Xi H; Liu Y; Li W
    Genet Test Mol Biomarkers; 2013 Jun; 17(6):489-93. PubMed ID: 23577780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a Vietnamese case-control cohort.
    Thanh NTN; Lan NTT; Phat PT; Giang NDT; Hue NT
    Genes Genet Syst; 2018 Oct; 93(3):101-109. PubMed ID: 30078824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Novel Breast Cancer Risk Loci.
    Chan CHT; Munusamy P; Loke SY; Koh GL; Wong ESY; Law HY; Yoon CS; Tan MH; Yap YS; Ang P; Lee ASG
    Cancer Res; 2017 Oct; 77(19):5428-5437. PubMed ID: 28775167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
    Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
    Hein R; Maranian M; Hopper JL; Kapuscinski MK; Southey MC; Park DJ; Schmidt MK; Broeks A; Hogervorst FB; Bueno-de-Mesquita HB; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Fasching PA; Hein A; Ekici AB; Beckmann MW; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Sawyer E; Tomlinson I; Kerin M; Miller N; Marmee F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Cordina-Duverger E; Menegaux F; Truong T; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Perez JI; Zamora MP; Benítez J; Anton-Culver H; Ziogas A; Bernstein L; Clarke CA; Brenner H; Müller H; Arndt V; Stegmaier C; Rahman N; Seal S; Turnbull C; Renwick A; Meindl A; Schott S; Bartram CR; Schmutzler RK; Brauch H; Hamann U; Ko YD; ; Wang-Gohrke S; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova NV; Zalutsky IV; Antonenkova NN; Bermisheva M; Prokovieva D; Farahtdinova A; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen J; Chen X; Beesley J; ; ; Lambrechts D; Zhao H; Neven P; Wildiers H; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Manoukian S; Barile M; Couch FJ; Olson JE; Wang X; Fredericksen Z; Giles GG; Baglietto L; McLean CA; Severi G; Offit K; Robson M; Gaudet MM; Vijai J; Alnæs GG; Kristensen V; Børresen-Dale AL; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Figueroa JD; García-Closas M; Lissowska J; Sherman ME; Hooning M; Martens JW; Seynaeve C; Collée M; Hall P; Humpreys K; Czene K; Liu J; Cox A; Brock IW; Cross SS; Reed MW; Ahmed S; Ghoussaini M; Pharoah PD; Kang D; Yoo KY; Noh DY; Jakubowska A; Jaworska K; Durda K; Złowocka E; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Yu JC; Hsu HM; Hou MF; Orr N; Schoemaker M; Ashworth A; Swerdlow A; Trentham-Dietz A; Newcomb PA; Titus L; Egan KM; Chenevix-Trench G; Antoniou AC; Humphreys MK; Morrison J; Chang-Claude J; Easton DF; Dunning AM
    PLoS One; 2012; 7(8):e42380. PubMed ID: 22879957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of genetic breast cancer susceptibility variants as prognostic factors.
    Fasching PA; Pharoah PD; Cox A; Nevanlinna H; Bojesen SE; Karn T; Broeks A; van Leeuwen FE; van't Veer LJ; Udo R; Dunning AM; Greco D; Aittomäki K; Blomqvist C; Shah M; Nordestgaard BG; Flyger H; Hopper JL; Southey MC; Apicella C; Garcia-Closas M; Sherman M; Lissowska J; Seynaeve C; Huijts PE; Tollenaar RA; Ziogas A; Ekici AB; Rauh C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Andrulis IL; Ozcelik H; Mulligan AM; Glendon G; Hall P; Czene K; Liu J; Chang-Claude J; Wang-Gohrke S; Eilber U; Nickels S; Dörk T; Schiekel M; Bremer M; Park-Simon TW; Giles GG; Severi G; Baglietto L; Hooning MJ; Martens JW; Jager A; Kriege M; Lindblom A; Margolin S; Couch FJ; Stevens KN; Olson JE; Kosel M; Cross SS; Balasubramanian SP; Reed MW; Miron A; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Chenevix-Trench G; ; Lambrechts D; Dieudonne AS; Hatse S; van Limbergen E; Benitez J; Milne RL; Zamora MP; Pérez JI; Bonanni B; Peissel B; Loris B; Peterlongo P; Rajaraman P; Schonfeld SJ; Anton-Culver H; Devilee P; Beckmann MW; Slamon DJ; Phillips KA; Figueroa JD; Humphreys MK; Easton DF; Schmidt MK
    Hum Mol Genet; 2012 Sep; 21(17):3926-39. PubMed ID: 22532573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
    Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low penetrance breast cancer predisposition SNPs are site specific.
    Mcinerney N; Colleran G; Rowan A; Walther A; Barclay E; Spain S; Jones AM; Tuohy S; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
    Breast Cancer Res Treat; 2009 Sep; 117(1):151-9. PubMed ID: 19005751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic predisposition to ductal carcinoma in situ of the breast.
    Petridis C; Brook MN; Shah V; Kohut K; Gorman P; Caneppele M; Levi D; Papouli E; Orr N; Cox A; Cross SS; Dos-Santos-Silva I; Peto J; Swerdlow A; Schoemaker MJ; Bolla MK; Wang Q; Dennis J; Michailidou K; Benitez J; González-Neira A; Tessier DC; Vincent D; Li J; Figueroa J; Kristensen V; Borresen-Dale AL; Soucy P; Simard J; Milne RL; Giles GG; Margolin S; Lindblom A; Brüning T; Brauch H; Southey MC; Hopper JL; Dörk T; Bogdanova NV; Kabisch M; Hamann U; Schmutzler RK; Meindl A; Brenner H; Arndt V; Winqvist R; Pylkäs K; Fasching PA; Beckmann MW; Lubinski J; Jakubowska A; Mulligan AM; Andrulis IL; Tollenaar RA; Devilee P; Le Marchand L; Haiman CA; Mannermaa A; Kosma VM; Radice P; Peterlongo P; Marme F; Burwinkel B; van Deurzen CH; Hollestelle A; Miller N; Kerin MJ; Lambrechts D; Floris G; Wesseling J; Flyger H; Bojesen SE; Yao S; Ambrosone CB; Chenevix-Trench G; Truong T; Guénel P; Rudolph A; Chang-Claude J; Nevanlinna H; Blomqvist C; Czene K; Brand JS; Olson JE; Couch FJ; Dunning AM; Hall P; Easton DF; Pharoah PD; Pinder SE; Schmidt MK; Tomlinson I; Roylance R; García-Closas M; Sawyer EJ
    Breast Cancer Res; 2016 Feb; 18(1):22. PubMed ID: 26884359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer.
    Adegoke OJ; Shu XO; Gao YT; Cai Q; Breyer J; Smith J; Zheng W
    Breast Cancer Res Treat; 2004 Jun; 85(3):239-45. PubMed ID: 15111762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.